Treatment strategies and subsequent changes in the patient-reported quality-of-life among elderly patients with atrial fibrillation

Miura, Kotaro; Ikemura, Nobuhiro; Kimura, Tokuhiro; Katsumata, Yoshinori; Ueda, Ikuko; Tanimoto, Kojiro; Ohki, Takahiro; Shinmura, Daisuke; Negishi, Koji; Fukuda, Keiichi; Takatsuki, Seiji; Kohsaka, Shun

doi:10.1016/j.ahj.2020.01.011

Cited by 19 publications

(14 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Identifying these factors might substantially affect anticipated QOL benefits of various AF therapies and can also help to identify potential challenges in adherence to therapy and self-care (see section 7.2). 79,80 5. Screening and Opportunistic AF Detection…”

Section: Risk Factor Role In Af Mechanismmentioning

confidence: 99%

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Andrade

Aguilar

Atzema

et al. 2020

Canadian Journal of Cardiology

428

496

View full text Add to dashboard Cite

The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was developed to aid clinicians in the management of these complex patients, as well as to provide direction to policy makers and health care systems regarding related issues. The most recent comprehensive CCS AF guidelines update was published R ESUM ELe programme de lignes directrices de la Soci et e canadienne de cardiologie (SCC) en matière de fibrillation auriculaire (FA) a et e elabor e pour aider les cliniciens à prendre en charge ces patients complexes, ainsi que pour orienter les d ecideurs politiques et les systèmes de soins de sant e sur des questions connexes. La dernière edition

show abstract

Section: Risk Factor Role In Af Mechanismmentioning

confidence: 99%

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Andrade

Aguilar

Atzema

et al. 2020

Canadian Journal of Cardiology

428

496

View full text Add to dashboard Cite

show abstract

“…The anticoagulation schedule does not include antiplatelet agents-such as Aspirin® (acetylsalicylic acid) and Plavix® (clopidogrel bisulfate), β-adrenergic blockers or calcium. Calcium channel blockers help in the rate of ventricular control, improve symptoms and have a low risk profile, but have low efficacy when it comes to reducing AF episodes [17].…”

Section: Discussionmentioning

confidence: 99%

Approach to Paroxysmal Atrial Fibrillation Type Arrhythmia in a Cardiology Service: A Case Report

Baron¹,

Dominguez²,

Isa³

et al. 2020

MRI

View full text Add to dashboard Cite

Atrial fibrillation is a cardiac arrhythmia of high prevalence in the population, especially in the elderly. Its main electrical characteristics are the interval between two successive irregular R waves, absence of P waves and presence of f waves between QRS complexes. The most common symptoms of atrial fibrillation are irregular palpitations associated with dyspnea, dizziness, feeling tired, fatigue and general malaise, but not all patients have any symptoms. The present report presents the history of an elderly patient who arrived at the hospital's emergency department with irregular heart rhythm and palpitations.

show abstract

“…The globally accepted threshold for old age is 65 years and widely available papers on rhythm control in the elderly describe patients aged over 65 or 70 years [3][4][5].While the mean age of patients in our previous publications on antazoline reached almost 70 years, for the purpose of this analysis we adapted 75 years as a threshold of old age [9,14,16].This age threshold is analogous to the age criterion for active monitoring for AF in clinical guidelines and consistent with recent studies on oral anticoagulation in the elderly [1,18]. Patients ≥ 75 years old comprised the study group and patients <75 years old comprised the control group.…”

Section: Methodsmentioning

confidence: 99%

“…While the initiation of oral anticoagulation is pretty clear in those patients, less is known about the optimal long-term strategy regarding rhythm or rate control [1]. Due to several factors like frailty or multimorbidity the rate control strategy seems to be prevalent in this population [1,[3][4][5]. Most concerns seem to be related to lower effectiveness and a higher risk of complications of typical rhythm control therapies in older patients [1].…”

Section: Introductionmentioning

confidence: 99%

Rapid pharmacological cardioversion of recent-onset atrial fibrillation using antazoline in elderly patients

Farkowski¹,

Maciąg²,

Zurawska³

et al. 2021

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

What's new?Our study conducted on 334 patients suggests that intravenous antazoline is similarly effective and safe for patients ≥75 and <75 years old in terms of conversion rates to sinus rhythm and risk of hospitalization due to adverse events. Therefore antazoline may be a viable option for the pharmacological cardioversion of recent-onset atrial fibrillation performed in the emergency department in the elderly while other fast acting agents may be contraindicated or simply not available.

show abstract

Treatment strategies and subsequent changes in the patient-reported quality-of-life among elderly patients with atrial fibrillation

Cited by 19 publications

References 25 publications

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Approach to Paroxysmal Atrial Fibrillation Type Arrhythmia in a Cardiology Service: A Case Report

Rapid pharmacological cardioversion of recent-onset atrial fibrillation using antazoline in elderly patients

Contact Info

Product

Resources

About